Patents by Inventor Rie Ouchi

Rie Ouchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210008123
    Abstract: Disclosed are methods of treating or reducing the occurrence of a steatohepatitis disorder. The disorder may include, for example, NASH, parenteral nutrition associated liver disease (PNALD), or genetic forms of liver disease. The method may comprise the step of administering a composition comprising obeticholic acid to an individual in need thereof.
    Type: Application
    Filed: April 24, 2020
    Publication date: January 14, 2021
    Inventors: Takanori Takebe, Rie Ouchi
  • Patent number: 10668108
    Abstract: Disclosed are methods of treating or reducing the occurrence of a steatohepatitis disorder. The disorder may include, for example, NASH, parenteral nutrition associated liver disease (PNALD), or genetic forms of liver disease. The method may comprise the step of administering a composition comprising obeticholic acid to an individual in need thereof.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: June 2, 2020
    Assignee: CHILDREN'S HOSPITAL MEDICAL CENTER
    Inventors: Takanori Takebe, Rie Ouchi
  • Publication number: 20200056157
    Abstract: Disclosed herein are methods of making and using lipotoxic organoid models. In certain aspects, the methods may comprise the steps of contacting a liver organoid with a free fatty acid (FFA) composition. In one aspect, the FFA composition may comprise oleic acid, linoleic acid, palmitic acid, or combinations thereof.
    Type: Application
    Filed: November 3, 2017
    Publication date: February 20, 2020
    Inventors: Takanori Takebe, Rie Ouchi, Masaki Kimura
  • Publication number: 20190314387
    Abstract: Disclosed are methods of treating or reducing the occurrence of a steatohepatitis disorder. The disorder may include, for example, NASH, parenteral nutrition associated liver disease (PNALD), or genetic forms of liver disease. The method may comprise the step of administering a composition comprising obeticholic acid to an individual in need thereof.
    Type: Application
    Filed: November 3, 2017
    Publication date: October 17, 2019
    Inventors: Takanori Takebe, Rie Ouchi